NuMask Versus Traditional Mask Ventilation During Routine Care

NCT ID: NCT02828280

Last Updated: 2017-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

44 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-05-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The direct objective of this study is to determine whether an experienced provider can more adequately and/or easily ventilate an anesthetized patient with the NuMask device as compared to traditional bag-valve-mask ventilation. These are approved masks, being used in the patients routine care. The researchers believe that mean tidal volumes obtained by experienced providers when manually ventilating anesthetized patients with the NuMask device will be larger than when using the traditional bag-valve-mask.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

NuMask

Pt's randomized to Numask first will be ventilated for 10 breaths with the NuMask device first, followed by 10 breaths with the traditional face mask

NuMask

Intervention Type DEVICE

The NuMask is a relatively new mask ventilation device that has been registered with the FDA and used in the United States since 2006.

Traditional mask

Intervention Type DEVICE

A traditional air inflated facemark used to ventilate patients

Traditional mask

patients randomized to traditional mask first will receive 10 breaths by traditional mask, followed by 10 breaths with NuMask

NuMask

Intervention Type DEVICE

The NuMask is a relatively new mask ventilation device that has been registered with the FDA and used in the United States since 2006.

Traditional mask

Intervention Type DEVICE

A traditional air inflated facemark used to ventilate patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

NuMask

The NuMask is a relatively new mask ventilation device that has been registered with the FDA and used in the United States since 2006.

Intervention Type DEVICE

Traditional mask

A traditional air inflated facemark used to ventilate patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 44 adults total
* ASA status I-III
* aged 18-64
* elective surgery at the University of Utah under general anesthesia
* Bearded, BMI \>35 or edentulous

Exclusion Criteria

* ASA IV or higher
* Oropharyngeal or facial pathology
* Risk of aspiration (defined by need for rapid sequence intubation, uncontrolled gastroesophageal reflux disease)
* Known and/or documented difficulty placing an endotracheal tube in the past
* Limited neck extension or flexion
* Personal or familial history of malignant hyperthermia
* Known or predicted severe respiratory disease or compromise
* Pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Derek Sakata

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Derek Sakata

M.D.

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Derek Sakata, MD

Role: PRINCIPAL_INVESTIGATOR

University of Utah

References

Explore related publications, articles, or registry entries linked to this study.

Caplan RA, Posner KL, Ward RJ, Cheney FW. Adverse respiratory events in anesthesia: a closed claims analysis. Anesthesiology. 1990 May;72(5):828-33. doi: 10.1097/00000542-199005000-00010.

Reference Type BACKGROUND
PMID: 2339799 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB_00042299

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Normal Saline Use With Suctioning
NCT02612961 COMPLETED NA